Basic fibroblast growth factor enema improves experimental colitis in rats

Hepato-Gastroenterology

Volumn 54, Issue 77, 2007, Pages 1373-1377

  Kojima, Tetsu ^a   Watanabe, Toshiaki ^a   Hata, Keisuke ^a   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Animal model; Basic fibroblast growth factor; Dextran sulfate sodium; Ulcerative colitis

Indexed keywords

DEXTRAN SULFATE; ENEMA; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; DISEASE ACTIVITY; DOSE RESPONSE; DRUG EFFECT; FECES ANALYSIS; HISTOPATHOLOGY; MALE; NONHUMAN; OCCULT BLOOD; PRIORITY JOURNAL; RAT; RECTUM HEMORRHAGE; SCORING SYSTEM; WEIGHT REDUCTION;

ANIMALS; COLITIS; ENEMA; FIBROBLAST GROWTH FACTOR 2; MALE; RATS; RATS, WISTAR;

EID: 34547631033     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Podolsky DK: Inflammatory bowel disease (1). N Engl J Med 1991; 325:928-937.
2. Beck PL, Podolsky DK: Growth factors in inflammatory bowel disease. Inflamm Bowel Dis 1999; 5:44-60.
3. Procaccino F, Reinshagen M, Hoffmann P, et al: Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology 1994; 107:12-17.
4. Egger B, Procaccino F, Sarosi I, et al: Keratinocyte growth factor ameliorates dextran sodium sulfate colitis in mice. Dig Dis Sci 1999; 44:836-844.
5. Jeffers M, McDonald WF, Chillakuru RA, et al: A novel human fibroblast growth factor treats experimental intestinal inflammation. Gastroenterology 2002; 123:1151-1162.
6. Tahara Y, Ido A, Yamamoto S, et al: Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther 2003; 307:146-151.
7. FitzGerald AJ, Pu M, Marchbank T, et al: Synergistic effects of systemic trefoil factor family 1 (TFF1) peptide and epidermal growth factor in a rat model of colitis. Peptides 2004; 25:793-801.
8. Arthur LG, Schwartz MZ, Kuenzler KA, Birbe R: Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease. J Pediatr Surg 2004; 39:139-143.
9. Sinha A, Nightingale J, West KP, et al: Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med 2003; 349:350-357.
10. Matsuura M, Okazalri K, Nishio A, et al: Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis. Gastroenterology 2005; 128:975-86.
11. Dignass AU, Tsunekawa S, Podolsky DK: Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology 1994; 106:1254-1262.
12. Szabo S, Folkman J, Vattay P, et al: Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats. Gastroenterology 1994; 106:1106-1111.
13. Fu X, Shen Z, Chen Y, et al: Randomised placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns. Lancet 1998; 352:1661-1664.
14. Payne WG, Ochs DE, Meltzer DD, et al: Long-term outcome study of growth factor-treated pressure ulcers. Am J Surg 2001; 181:81-86.
15. Ohtani H, Nakamura S, Watanabe Y, et al: Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab Invest 1993; 68:520-527.
16. Bousvaros A, Zurakowski D, Fishman SJ, et al: Serum basic fibroblast growth factor in pediatric Crohn's disease. Implications for wound healing. Dig Dis Sci 1997; 42:378-386.
17. Zeeh JM, Procaccino F, Hoffmann P, et al: Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology 1996; 110:1077-1083.
18. Miceli R, Hubert M, Santiago G, et al: Efficacy of keratinocyte growth factor-2 in dextran sulfate sodium-induced murine colitis. J Pharmacol Exp Ther 1999; 290:464-471.
19. Cooper HS, Murthy SN, Shah RS, Sedergran DJ: Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69:238-249.
20. Polnaszek N, Kwabi-Addo B, Peterson LE, et al: Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Cancer Res 2003; 63:5754-5760.
21. Sepp NT, Li LJ, Lee KH, et al: Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cells. J Invest Dermatol 1994; 103:295-299.
22. Houchen CW, George RJ, Sturmoski MA, Cohn SM: FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury. Am J Physiol 1999; 276:G249-258.
23. Tessner TG, Muhale F, Schloemann S, et al: Basic fibroblast growth factor upregulates cyclooxygenase-2 in 1407 cells through p38 MAP kinase. Am J Physiol Gastrointest Liver Physiol 2003; 284:G269-279.
24. Konishi H, Ochiya T, Yasuda Y, et al: HST-1/FGF-4 stimulates proliferation of megakaryocyte progenitors synergistically and promotes megakaryocyte maturation. Oncogene 1996; 13:9-19.
25. Zhou M, Sutliff RL, Paul RJ, et al: Fibroblast growth factor 2 control of vascular tone. Nat Med 1998; 4:201-207.
26. Gu Q, Wang D, Wang X, et al: Basic fibroblast growth factor inhibits radiation-induced apoptosis of HUVECs. II. The RAS/MAPK pathway and phosphorylation of BAD at serine 112. Radiat Res 2004; 161:703-711.
27. Murai N, Ueba T, Takahashi JA, et al: Apoptosis of human glioma cells in vitro and in vivo induced by a neutralizing antibody against human basic fibroblast growth factor. J Neurosurg 1996; 85:1072-1077.
28. Konig A, Menzel T, Lynen S, et al: Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis. Leukemia 1997; 11:258-265.